17
Hemofilie
Nilsson IM, Berntorp E,
Löfqvist T,et al. Twentyfive
years experience of prop-
hylactic treatment in severe
haemophilia A and B. J Intern
Med 1992; 232: 25–32.
van den Berg HM, Fischer
K, Mauser-Bunschoten
EP, et al. Long-term
outcome of individualized
prophylactic treatment
of children with severe
haemophilia.
Br
J
Haematol 2001; 112:
561–565.
Astermark J, Petrini P,
Tengborn L, et al. Primary
prophylaxis in severe
haemophilia should be
started at an early age
but can be individualized.
Br J Haematol 1999; 105:
1109–1113.
Fischer K, van der Bom
JG, Mauser-Bunschoten
EP, et al. The effects of
postponing prophylactic
treatment on long-term
outcome in patients
with severe haemop-
hilia. Blood 2002; 99:
2337–2341.
Fischer K, Grobbee DE,
van den Berg HM. RCTs
and observational studies
to determine the effect
of prophylaxis in severe
haemophilia. Haemophilia
2007; 13: 345–350.
Manco-Johnson
MJ,
Abshire TC, Shapiro AD,
et al. Prophylaxis versus
episodic treatment to
prevent joint disease in
boys with severe hemop-
hilia. N Engl J Med 2007;
357: 535–544.
Gringeri A, Lundin B,
Mackensen SV, Manto-
vani L, Mannucci PM; and
the ESPRIT Study Group.
A Randomized Clinical
Trial of Prophylaxis in
Children with Hemophilia
A (the ESPRIT Study). J
Thromb Haemost. 2011
Jan 21. doi: 10.1111/j.1538-
7836.2011.04214.
x. [Epub
ahead of print]
Santagostino E, Mancuso
M, Gringeri A, et al. Low-
rate of complications after
a long-term use of arte-
riovenous fistula (AVF)
in hemophilic children.
Haemophilia 2008; 14
(
Suppl 2): 99 [Abstract].
Fischer K, Astermark J,
van der Bom JG, et al.
Prophylactic treatment
for severe haemophilia:
comparison of an interme-
diate-dose to a high-dose
regimen.
Haemophilia
2002; 8: 753–760.
Fischer K, van der
Bom JG, Prejs R, et al.
Discontinuation of prop-
hylactic therapy in severe
haemophilia: incidence
and effects on outcome.
Haemophilia 2001; 7:
544–550.
van Dijk K, Fischer K, van
der Bom JG, et al. Can long
term prophylaxis for severe
haemophilia be stopped in
adulthood? Results from
Denmark and the Nether-
lands. Br J Haematol 2005;
130: 107–112.
Tagliaferri A, Franchini M,
Coppola A, et al. Effects
of secondary prophylaxis
started in young-adult
hemophiliacs. Haemop-
hilia 2008; 14: 945–951.
Onder de talrijke geconsulteerde documenten,
doet de auteur een aanbeveling voor de lectuur
van volgende artikels: